Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-06
2007-11-06
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S298000, C544S327000, C544S328000
Reexamination Certificate
active
11192961
ABSTRACT:
This invention relates to methods for treating sexual dysfunction, by administering a compound of the formulawherein R1is H or a di-C1-6-alkylaminocarbonyl radical, and R2is a radical of the formula —O—C(X)—NR3R4wherein X is O or S. The compound may also be administered in combination with at least one organic nitrate or NO donor, or in combination with at least one compound which inhibits the breakdown of cyclic guanosine monophosphate (cGMP).
REFERENCES:
patent: 6166027 (2000-12-01), Straub et al.
patent: 6180656 (2001-01-01), Furstner et al.
patent: 6387940 (2002-05-01), Straub et al.
patent: 6410740 (2002-06-01), Straub et al.
patent: 6414009 (2002-07-01), Straub et al.
patent: 6451805 (2002-09-01), Straub et al.
patent: 6462068 (2002-10-01), Straub et al.
patent: 7105523 (2006-09-01), Stasch et al.
patent: 9816223 (1998-04-01), None
patent: 9816507 (1998-04-01), None
patent: 9823619 (1998-05-01), None
patent: 0006567 (2000-02-01), None
patent: 0006568 (2000-02-01), None
patent: 0006569 (2000-02-01), None
patent: 0021954 (2000-04-01), None
Vemulapalli et al., Medline Abstract (Life Sciences, vol. 67, Issue 1, pp. 23-29) May 2000.
Weidmann, PubMed Abstract (Ther Umsch 55(6):384-8) Jun. 1998.
Ko et al., “YC-1, a Novel Activator of Platelet Guanylate Cyclase”, Blood 84 4226-4233 (1994).
Mulsch, et al., “Effect of YC-1, and NO-independent, Superoxide-Sensitive stimulator of Soluble Guanylyl Cyclase, on Smooth Muscle Responsiveness to Nitrovasodilators”, Brit. J. of Pharmacol. 120 681-689 (1997).
Glass et al., “Stimulation of Human Platelet Guanylate Cyclase by Fatty Acids”, J. of Biol. Chem. 252 1279-1285 (1977).
Pettibone et al., “A Structurally Novel Stimulator of Guanylate Cyclase with Long-lasting Hypotensive Activity in the Dog”. Euro. J. of Pharmacol. 116, 307-312 (1985).
Yu et al., “Vasorelaxant Effect of Isoliquiritigenin, a Novel Soluble Gyanylate Cyclase Activator, in Rat Aorta” Brit. J. of Pharmacol. 114 1587-1594 (1995).
Damasio,Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.
Layzer, Robert B., Degenerative Diseases of the Nervous system, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.
Wolin, et al. Review: Oxidant-NO Signalling Mechanism in Vascular Tissue, Biochemistry (Moscow), vol. 63, No. 7, 810/958, 1998.
Prandoni, The treatment of venous thromboembolic disorders: new challenges and opportunities, Haematologica/Journal of Haematology, vol. 88(05), pp. 610-613, 2003.
Fisker et al., PubMed Abstract (J. Endocrin Invest. 22 (5 Supply): 89-93), 1999.
Alonso-Alija Cristina
Dembowsky Klaus
Feurer Achim
Flubacher Dietmar
Lang Dieter
Bayer Aktiengesellschaft
Rao Deepak
LandOfFree
Medical uses of carbamate-substituted pyrazolo-pyridine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical uses of carbamate-substituted pyrazolo-pyridine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical uses of carbamate-substituted pyrazolo-pyridine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3825133